Regeneron Pharmaceuticals (REGN) Q4 2025 Earnings

28OctConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
8.22
9.78
11.33
12.89

Details

Expected EPS
9.654543
Actual EPS
11.83
Surprise EPS
2.18
Surprise Percent
+22.53%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 11.83 per share for Q4 2025.

0 Comments

Share your thoughts